The Scientist

» drug development

Most Recent

image: Stress and Inflammation

Stress and Inflammation

By | February 1, 2011

Stress and inflammation Cardiovascular disease, including coronary artery disease and stroke, is the single greatest cause of death worldwide and is a major burden on health services and society. 

0 Comments

image: When Stress Is Good

When Stress Is Good

By | February 1, 2011

Fast blood flow protects against atherosclerosis: implications for treatment

0 Comments

image: The Genes of Parkinson’s Disease

The Genes of Parkinson’s Disease

By | February 1, 2011

The minority of Parkinson’s cases now known to have genetic origins are shedding light on the cellular mechanisms of all the rest, bringing researchers closer to a cause—and perhaps a cure.

1 Comment

image: Puzzle Me This

Puzzle Me This

By | February 1, 2011

What substance is supposed to have no effect but can make people feel better, has no chance for a big monetary payoff but is worth billions, and is used in virtually every rigorous clinical trial but has no single, universal formulation? 

0 Comments

image: Mining Bacterial Small Molecules

Mining Bacterial Small Molecules

By | January 1, 2011

As much as rainforests or deep-sea vents, the human gut holds rich stores of microbial chemicals that should be mined for their pharmacological potential.

0 Comments

image: Brave New Drugs

Brave New Drugs

By | January 1, 2011

Intoxicating ideas for saving a billion lives

0 Comments

image: The Profits of Nonprofit

The Profits of Nonprofit

By | January 1, 2011

The surprising results when drug development and altruism collide

9 Comments

image: Top 7 From F1000

Top 7 From F1000

By | January 1, 2011

A snapshot of the highest-ranked articles from a 30-day period on Faculty of 1000

0 Comments

Botanical Biopharming

By | September 1, 2010

Green-thumbed biotechs say they can use plants to make drugs faster, cheaper, and better than top pharmaceutical companies.

3 Comments

image: Betting on Biotech

Betting on Biotech

By | April 5, 1993

Despite chill winds on Wall Street, investors continue to place bets on fledgling biotechnology companies.

0 Comments

Popular Now

  1. 2017 Top 10 Innovations
    Features 2017 Top 10 Innovations

    From single-cell analysis to whole-genome sequencing, this year’s best new products shine on many levels.

  2. Thousands of Mutations Accumulate in the Human Brain Over a Lifetime
  3. Antiviral Immunotherapy Comes of Age
    News Analysis Antiviral Immunotherapy Comes of Age

    T-cell therapies are not just for cancer. Researchers are also advancing immunotherapy methods to protect bone marrow transplant patients from viral infections. 

  4. Search for Life on the Red Planet
FreeShip